Russell Investments Group
PMVP icon

Russell Investments Group’s PMV Pharmaceuticals PMVP Stock Holding History

Russell Investments Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,711
Closed -$7.63K – 3774
2024
Q2 		$7.63K Buy
+4,711
New +$8.5K ﹤0.01% 3138
2023
Q3 		– Sell
-1,592
Closed -$9.96K – 3606
2023
Q2 		$9.96K Hold
1,592
– – ﹤0.01% 2966
2023
Q1 		$7.59K Hold
1,592
– – ﹤0.01% 2918
2022
Q4 		$13.8K Hold
1,592
– – ﹤0.01% 2829
2022
Q3 		$18K Sell
1,592
-549
-26% -$7.93K ﹤0.01% 2818
2022
Q2 		$30K Buy
+2,141
New +$31.2K ﹤0.01% 2764

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group's PMVP Position: Q3 2024 in Review

Russell Investments Group sold out of PMV Pharmaceuticals (PMVP) in Q3 2024, closing a stake of 4,711 shares — an estimated $7.63K sold.

Russell Investments Group first reported a position in PMVP in Q2 2022 and held it in 6 quarters. The position peaked at $30K in Q2 2022. 74 funds tracked by Wall St. Rank hold PMVP as of Q3 2024.

  • Russell Investments Group reported no remaining PMV Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 4,711 PMV Pharmaceuticals shares in Q3 2024, an estimated $7.63K.
  • Russell Investments Group first reported a position in PMV Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • Russell Investments Group's PMV Pharmaceuticals position peaked at $30K in Q2 2022.
  • 74 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.